The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase.
about
Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosisPhosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cellsLoss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancerOver-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinomaImmunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cellsThe Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilyPotentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activityArsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potentialContribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma TreatmentsEstrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.A site-specific, multiplexed kinase activity assay using stable-isotope dilution and high-resolution mass spectrometry.Synchronization in G0/G1 enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin.GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.Complexity of receptor tyrosine kinase signal processing.Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells.Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells.Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.Acquired resistance to drugs targeting receptor tyrosine kinasesResearch progress on criteria for discontinuation of EGFR inhibitor therapy.Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.Activation of the mammalian target of rapamycin complex 1 is both necessary and sufficient to stimulate eukaryotic initiation factor 2Bvarepsilon mRNA translation and protein synthesis.Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.Targeting EGFR resistance networks in head and neck cancer.The "cryptic" mechanism of action of glucagon-like peptide-2.Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3.Receptor binding specificities of Herstatin and its intron 8-encoded domain.Phosphorylated insulin-like growth factor 1 receptor is implicated in resistance to the cytostatic effect of gefitinib in colorectal cancer cells.Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells.Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer.Transactivation of epidermal growth factor receptor by insulin-like growth factor 1 requires basal hydrogen peroxide.Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1.Acquired Resistance to Drugs Targeting Tyrosine Kinases.
P2860
Q24314721-C8294166-FB94-4A56-9232-F804518AF1D5Q24338435-574A0130-B57A-4F79-8F5F-623704CC1B8DQ24653934-050EB519-4B6D-4A53-85FD-9A91EA061B63Q24796051-5C4396F9-36F2-410A-B28A-CDB3BF1D80AAQ24796824-C3EB35DB-A055-4CD1-A97C-CD95C5668C03Q27318931-5E54D6A5-45AC-4D23-B0AE-BD12D57BA6C7Q28073335-EF0B68DE-1FF3-419B-840B-8AA267E08F45Q28253045-05E36E44-A56D-4EA8-89AA-1E31325CAE45Q28396530-F16642E3-EDB1-4995-B0FF-892E943C7D71Q28547357-63B3296E-7D7E-4A41-BAF9-F2676726D0D5Q30433113-1D7B1242-DE68-4EB8-971D-D77B23B44A1EQ30438933-5D538F0A-0E9C-4339-AB72-3B4348A08875Q33476095-010986DD-F052-4FEE-9EA7-BAB2E84BE0B0Q33959945-D207E91C-264C-4EFD-A4E8-CDCB0DA0FD36Q34066386-6092EC0B-79CC-452F-9D64-1EE547C8A940Q34361161-26F4D403-DA7A-4D46-9CDC-40CF94272F5AQ34569071-82D31D72-9F22-469D-997E-AF87D2148855Q35153546-85BA25E3-2A8F-4F64-9D3E-39AED8490D0FQ35212113-73CE5D2B-2B08-4FB4-B45B-2E1E411CD4CEQ35221829-67CE5CA0-51D0-4EB4-B065-935896F45A48Q35823437-53CDD6E3-053D-4A4E-98D0-B60D50D1D6B5Q36330264-45140EDC-263E-4346-8848-5BA091CFCA7DQ36850793-9E967D80-8EA2-4E7B-9A1A-9C7817374CECQ36904280-B36D07A1-5DD9-48F5-845B-B62371635A36Q37012797-16A43444-8E62-4A79-BCFA-90D983E47CFEQ37321835-417B549D-A69A-4160-A77A-CA35390099E2Q37405633-6923CC7C-3CFC-4E18-8AC0-11FA0AD7A000Q37870031-2079C09E-AC72-40F2-A894-0EE68781A994Q37927102-F2EAB347-CC0A-4183-91AD-D5FA3CC1D3BFQ38340100-BDD8AF72-C387-4093-8FCA-6FB68780EC62Q39561256-B3DD6E07-1CAA-4393-8EE1-FBB7596667FBQ39645865-0CA6DDA5-A0C3-4207-9F38-7FFE00680AC9Q39769976-5A49B2E7-B215-46FB-967B-46C619C8C0EBQ40232484-DF4D76D2-1E2C-4EA7-A256-F27E0E664881Q40462263-CF75528B-7F92-473B-BDE5-D5C0D2BAC71FQ42488033-18BDAACF-E719-46DD-A168-74C5D9012C38Q53701267-5C666E1B-A62B-4566-AC31-CE9C0A927DB8
P2860
The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@ast
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@en
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@nl
type
label
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@ast
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@en
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@nl
prefLabel
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@ast
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@en
The mitogenic action of insuli ...... ctor receptor tyrosine kinase.
@nl
P2093
P2860
P356
P1476
The mitogenic action of insuli ...... actor receptor tyrosine kinase
@en
P2093
Neil G Anderson
Nigel J Bundred
Tawhid Ahmad
P2860
P304
P356
10.1074/JBC.M306156200
P407
P577
2003-10-30T00:00:00Z